Abnormal metabolites in the dorsolateral prefrontal cortex of female epilepsy patients with migraine without aura

Liping Wang,Huaxia Pu,Jingyuan Zhou,Wenyu Liu,Shujiang Zhang,Qiaoyue Tan,Xinyue Wan,Weina Wang,Dong Zhou,Qiang Yue,Qiyong Gong
DOI: https://doi.org/10.1097/wnr.0000000000002110
2024-11-13
Neuroreport
Abstract:Epilepsy is a condition characterized by sudden, short-lived, and repetitive brain malfunctions due to abnormal discharge of brain neuron activity [ 1 ]. It can last for years or decades, and prolonged seizures are often accompanied by many comorbidities [ 1 , 2 ]. Migraine, one of the most common comorbidities, is a chronic neurovascular disorder characterized by unilateral or bilateral episodic headaches [ 3 , 4 ]. Although epilepsy and migraine are two heterogeneous diseases, they are both recurrent, transient, and paroxysmal chronic neurological disorders that often occur simultaneously or successively in the same patient and have certain correlations in epidemiology, clinical characteristics, pathogenetic mechanisms, and treatments [ 3 , 5–7 ]. Patients with epilepsy comorbid with migraine were more likely to have symptoms such as depression and anxiety than those without migraine [ 8 ], which further increases the disease burden. Migraine includes two main clinical subtypes: migraine with aura (MWA) and migraine without aura (MWoA) [ 9 ]. Of these, MWoA is more common [ 9 ], and when comorbid with epilepsy, it is easily misdiagnosed because of the absence of aura symptoms. However, the specific mechanisms of epilepsy comorbid with MWoA (EWM) remain unclear. Therefore, it is necessary to explore the mechanisms of EWM.
neurosciences
What problem does this paper attempt to address?